Elevance Health Inc. (ELV) Business Metric Overview - Stocknear

Elevance Health Inc.

NYSE: ELV · Real-Time Price · USD
313.59
5.54 (1.80%)
At close: Sep 05, 2025, 3:59 PM
314.00
0.13%
After-hours: Sep 05, 2025, 07:56 PM EDT

Elevance Health Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Carelon Services Segment Revenue 18.08B 16.65B n/a 27.56B 26.64B 24.15B 25.69B 23.78B 23.81B 22.67B
Carelon Services Segment Revenue Growth +8.60% n/a -100.00% +3.47% +10.29% -6.00% +8.03% -0.13% +5.04% n/a
Health Benefits Segment Revenue 41.58B 41.43B 37.58B 38.28B 37.16B 37.26B 36.55B 36.74B 38B 37.28B
Health Benefits Segment Revenue Growth +0.36% +10.25% -1.82% +3.01% -0.27% +1.95% -0.54% -3.31% +1.93% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue n/a n/a n/a n/a n/a n/a n/a n/a 4.82B 4.8B 4.56B 4.51B 4.27B 4.34B 4.22B 3.95B 3.82B 3.92B 4.32B 5.3B 4.05B 3.78B 3.5B 3.42B 3.28B 3.17B 3.62B 3.55B 3.43B 3.43B 3.39B 3.01B 3.05B 3.19B 3.26B 3.12B 2.97B 3.2B 3.27B 3.08B 3.04B 3.15B
Selling, General, and Administrative Revenue Growth n/a n/a n/a n/a n/a n/a n/a -100.00% +0.38% +5.22% +1.06% +5.66% -1.68% +2.91% +6.99% +3.27% -2.65% -9.10% -18.61% +31.12% +7.01% +7.97% +2.46% +4.27% +3.54% -12.49% +2.03% +3.44% 0.00% +1.02% +12.70% -1.40% -4.31% -2.23% +4.46% +5.24% -7.22% -2.09% +6.10% +1.30% -3.32% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a